Veterinary Research

The rapamycin trial in dogs, and why it will not answer the question until 2029

TRIAD is randomised, double-blind and placebo-controlled, with lifespan as its primary endpoint. That design is the reason it is slow, and the reason it will be worth reading when it reports.